CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients
Open accessAbstract
Significance: In type 1 diabetes (T1D), the insulin-producing pancreatic β-cells are destroyed by the immune system. Both genetic and environmental factors contribute to T1D risk. Candidate genes for T1D identified by genome-wide association studies have been proposed to act at both the immune system and the β-cell levels. This study shows that the risk variant rs3825932 in the candidate gene cathepsin H ( CTSH ) predicts β-cell function in both model systems and human T1D. Collectively, our data indicate that higher CTSH expression in β-cells may protect against immune-mediated damage and preserve β-cell function, thereby representing a possible therapeutic target. Our study reinforces the concept that candidate genes for T1D may affect disease progression by modulating survival and function of the β-cells.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Over 40% of genes associated with type 1 diabetes are expressed in the islet or beta cell.
“More recently, there has been increased focus on whether many of these variants may influence beta cell interactions with the immune system, with over 40% of genes associated with type 1 diabetes being expressed in the islet or beta cell.”
From 100 years of insulin: celebrating the past, present and future of diabetes therapy (2021) · cites this paper as [56]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Droga-Mazovec, G., Bojič, L., Petelin, A., Ivanova, S., Romih, R., Repnik, U., Salvesen, G. S., Stoka, V., Turk, V., & Turk, B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802513200 · Cited by 399 · see citing works
Poulsen, P., Levin, K., Petersen, I., Christensen, K., Beck-Nielsen, H., & Vaag, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.275 · Cited by 166 · see citing works
Self-citationBergholdt, R., Brorsson, C., Palleja, A., Berchtold, L. A., Fløyel, T., Bang-Berthelsen, C. H., Frederiksen, K. S., Jensen, L. J., Størling, J., & Pociot, F. (2012) · Diabetes · doi:10.2337/db11-1263 · Cited by 125 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 31
- Eizirik DL, Colli ML, Ortis F (2009) The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 5(4):219-226.
- Barrett JC, et al.; Type 1 Diabetes Genetics Consortium (2009) Genome-wide associ- ation study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41(6):703-707.
- Eizirik DL, et al. (2012) The human pancreatic islet transcriptome: Expression of can- didate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 8(3):e1002552.
- Schaub MA, Boyle AP, Kundaje A, Batzoglou S, Snyder M (2012) Linking disease as- sociations with regulatory information in the human genome. Genome Res 22(9): 1748-1759.
- Cooper JD, et al. (2008) Meta-analysis of genome-wide association study data iden- tifies additional type 1 diabetes risk loci. Nat Genet 40(12):1399-1401.
- Conus S, Simon HU (2008) Cathepsins: Key modulators of cell death and inflammatory responses. Biochem Pharmacol 76(11):1374-1382.
- Reiser J, Adair B, Reinheckel T (2010) Specialized roles for cysteine cathepsins in health and disease. J Clin Invest 120(10):3421-3431.
- Maehr R, et al. (2005) Cathepsin L is essential for onset of autoimmune diabetes in NOD mice. J Clin Invest 115(10):2934-2943.
- Hsing LC, et al. (2010) Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse. J Autoimmun 34(2):96-104.
- Zou F, et al. (2011) Regulation of cathepsin G reduces the activation of proinsulin- reactive T cells from type 1 diabetes patients. PLoS ONE 6(8):e22815.
- Korpos É, et al. (2013) The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human. Diabetes 62(2):531-542.
- Cirman T, et al. (2004) Selective disruption of lysosomes in HeLa cells triggers apo- ptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 279(5):3578-3587.
- D'Angelo ME, et al. (2010) Cathepsin H is an additional convertase of pro-granzyme B. J Biol Chem 285(27):20514-20519.
- Gocheva V, Chen X, Peters C, Reinheckel T, Joyce JA (2010) Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer. Biol Chem 391(8):937-945.
- Lu WD, et al. (2012) Cathepsin H functions as an aminopeptidase in secretory vesicles for production of enkephalin and galanin peptide neurotransmitters. J Neurochem 122(3):512-522.
- Stranger BE, et al. (2007) Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315(5813):848-853.
- Zeller T, et al. (2010) Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS ONE 5(5):e10693.
- Donath MY, Størling J, Berchtold LA, Billestrup N, Mandrup-Poulsen T (2008) Cyto- kines and beta-cell biology: From concept to clinical translation. Endocr Rev 29(3): 334-350.
- Eizirik DL, Mandrup-Poulsen T (2001) A choice of death-the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44(12):2115-2133.
- Mortensen HB, et al.; Hvidoere Study Group on Childhood Diabetes (2009) New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care 32(8):1384-1390.
- Im B, Kominami E, Grube D, Uchiyama Y (1989) Immunocytochemical localization of cathepsins B and H in human pancreatic endocrine cells and insulinoma cells. Histo- chemistry 93(2):111-118.
- Cardozo AK, et al. (2001) A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J Biol Chem 276(52):48879-48886.
- Santin I, et al. (2011) PTPN2, a candidate gene for type 1 diabetes, modulates pan- creatic β-cell apoptosis via regulation of the BH3-only protein Bim. Diabetes 60(12): 3279-3288.
- Gurzov EN, et al. (2009) Signaling by IL-1beta+IFN-gamma and ER stress converge on DP5/Hrk activation: A novel mechanism for pancreatic beta-cell apoptosis. Cell Death Differ 16(11):1539-1550.
- Nogueira TC, et al. (2013) GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3- only protein Bim. PLoS Genet 9(5):e1003532.
- Bhatnagar S, et al. (2011) Positional cloning of a type 2 diabetes quantitative trait locus; tomosyn-2, a negative regulator of insulin secretion. PLoS Genet 7(10): e1002323.
- Colli ML, Moore F, Gurzov EN, Ortis F, Eizirik DL (2010) MDA5 and PTPN2, two can- didate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by- product double-stranded RNA. Hum Mol Genet 19(1):135-146.
- Moore F, et al. (2009) PTPN2, a candidate gene for type 1 diabetes, modulates interferon-gamma-induced pancreatic beta-cell apoptosis. Diabetes 58(6):1283-1291.
- Berchtold LA, et al. (2011) Huntingtin-interacting protein 14 is a type 1 diabetes candidate protein regulating insulin secretion and beta-cell apoptosis. Proc Natl Acad Sci USA 108(37):E681-E688.
- Bühling F, et al. (2011) Gene targeting of the cysteine peptidase cathepsin H impairs lung surfactant in mice. PLoS ONE 6(10):e26247.
- Mortensen HB, et al.; Hvidoere Study Group on Childhood Diabetes (2010) Multina- tional study in children and adolescents with newly diagnosed type 1 diabetes: As- sociation of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis. Pediatr Diabetes 11(4): 218-226.
Cited by
Sorted by citations
Genetic risk factors for type 1 diabetes
Pociot, F., & Lernmark, Å. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30582-7 · Cited by 553 · see citing works
Self-citationViral infections in type 1 diabetes mellitus — why the β cells?
Op de Beeck, A., & Eizirik, D. L. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.30 · Cited by 291 · see citing works
Self-citation100 years of insulin: celebrating the past, present and future of diabetes therapy
Sims, E. K., Carr, A. L. J., Oram, R. A., DiMeglio, L. A., & Evans-Molina, C. (2021) · Nature Medicine · doi:10.1038/s41591-021-01418-2 · Cited by 270 · see citing works
Metabolomics of type 1 and type 2 diabetes
Arneth, B., Arneth, R., & Shams, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102467 · Cited by 262 · see citing works
- Authors
- Fløyel, T., Brorsson, C., Nielsen, L. B., Miani, M., Bang-Berthelsen, C. H., Friedrichsen, M., Overgaard, A. J., Berchtold, L. A., Wiberg, A., Poulsen, P., Hansen, L., Rosinger, S., Boehm, B. O., Ram, R., Nguyen, Q., Mehta, M., Morahan, G., Concannon, P., Bergholdt, R., Nielsen, J. H., Reinheckel, T., von Herrath, M., Vaag, A., Eizirik, D. L., Mortensen, H. B., Størling, J., & Pociot, F.
- Affiliations
- Herlev Hospital (DK)
- Université Libre de Bruxelles (BE)
- Department of Pediatrics, Herlev University Hospital, 2730 Herlev, Denmark;
- Rigshospitalet (DK)
- La Jolla Institute for Immunology (US)
- Novo Nordisk (Denmark) (DK)
- Universität Ulm (DE)
- Nanyang Technological University (SG)
- The University of Western Australia (AU)
- University of Florida (US)
- University of Copenhagen (DK)
- University of Freiburg (DE)
- Type 1 Diabetes Center, La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037;
- ORCID
- Fløyel, Tina
- Brorsson, Caroline
- Nielsen, Lotte B.
- Miani, Michela
- Friedrichsen, Martin
- Overgaard, Anne Julie
- Wiberg, Anna
- Boehm, Bernhard O.
- Ram, Ramesh
- Mehta, Munish
- Morahan, Grant
- Concannon, Patrick
- Nielsen, Jens H.
- Reinheckel, Thomas
- Vaag, Allan
- Eizirik, Decio Laks
- Mortensen, Henrik B.
- Størling, Joachim
- Pociot, Flemming
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-06-30
- Volume
- 111
- Issue
- 28
- Pages
- 10305-10310
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4104872
- OpenAlex
- W2146237406
- Cited by
- 104
- References
- 3
- Citations by year
- 2026: 2 · 2025: 16 · 2024: 13 · 2023: 4 · 2022: 4 · 2021: 10 · 2020: 9 · 2019: 7 · 2018: 10 · 2017: 6 · 2016: 9 · 2015: 13 · 2014: 1
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion, other-oa)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- DR-NTU (Nanyang Technological University) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DP3DK085678, R01DK046635)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- cathepsin H, type 1 diabetes, disease progression, beta-cell function, beta-cell apoptosis, inflammatory cytokines, JNK signaling, p38 MAPK, building information modeling, c-Myc, Ins2, insulin secretion, genetic susceptibility, newly diagnosed type 1 diabetes, glucose tolerance
- MeSH terms
- Adolescent, Alleles, Animals, Cell Line, Child, Child, Preschool, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1, Gene Expression Regulation, Genotype, Humans, Apoptosis, Mice, Knockout, Insulin-Secreting Cells, Mice, Rats, Cathepsin H
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review